CA2018167A1 - Comprime a delitement progressif - Google Patents
Comprime a delitement progressifInfo
- Publication number
- CA2018167A1 CA2018167A1 CA2018167A CA2018167A CA2018167A1 CA 2018167 A1 CA2018167 A1 CA 2018167A1 CA 2018167 A CA2018167 A CA 2018167A CA 2018167 A CA2018167 A CA 2018167A CA 2018167 A1 CA2018167 A1 CA 2018167A1
- Authority
- CA
- Canada
- Prior art keywords
- sustained release
- gastro
- release pharmaceutical
- pharmaceutical tablet
- intestinal tract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/363,038 US5002774A (en) | 1989-06-08 | 1989-06-08 | Sustained release pharmaceutical tablet |
US363,038 | 1989-06-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2018167A1 true CA2018167A1 (fr) | 1990-12-08 |
CA2018167C CA2018167C (fr) | 1999-03-23 |
Family
ID=23428524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002018167A Expired - Lifetime CA2018167C (fr) | 1989-06-08 | 1990-06-04 | Comprime a delitement progressif |
Country Status (2)
Country | Link |
---|---|
US (1) | US5002774A (fr) |
CA (1) | CA2018167C (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5268181A (en) * | 1989-04-13 | 1993-12-07 | Upsher-Smith Laboratories, Inc. | Method of using niacin to control nocturnal cholesterol synthesis |
FR2677546B1 (fr) * | 1991-06-12 | 1994-01-21 | Fabienne Joanny | Composition therapeutique pour liberation prolonge de magnesium. |
US5407686A (en) * | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
US5292534A (en) * | 1992-03-25 | 1994-03-08 | Valentine Enterprises, Inc. | Sustained release composition and method utilizing xanthan gum and an active ingredient |
ATE183086T1 (de) * | 1992-04-15 | 1999-08-15 | Alteon Inc | Aminoguanidin-spruehtrocknungsverfahren |
US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
US6676967B1 (en) | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
US5451409A (en) * | 1993-11-22 | 1995-09-19 | Rencher; William F. | Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends |
DE69530973T2 (de) * | 1994-02-16 | 2004-05-19 | Abbott Laboratories, Abbott Park | Verfahren zur herstellung feinteiliger pharmazeutischer formulierungen |
DE69940557D1 (de) | 1998-12-11 | 2009-04-23 | Nostrum Pharmaceuticals Inc | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung |
NZ517466A (en) | 1999-09-02 | 2003-11-28 | Nostrum Pharmaceuticals Inc | Controlled release oral dosage suitable for oral administration |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
RU2230556C2 (ru) | 1999-10-29 | 2004-06-20 | Эро-Селтик, С.А. | Препаративные формы гидрокодона с контролируемым высвобождением |
AU2002227383B2 (en) | 2000-10-30 | 2004-07-08 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
US6887492B2 (en) | 2000-12-14 | 2005-05-03 | Leiner Health Services Corp. | Magnesium plus interactive agent delivery |
US20030203055A1 (en) * | 2002-03-15 | 2003-10-30 | Cypress Bioscience, Inc. | Methods of treating visceral pain syndromes |
US20040132826A1 (en) * | 2002-10-25 | 2004-07-08 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
US20060003004A1 (en) * | 2002-10-25 | 2006-01-05 | Collegium Pharmaceutical, Inc. | Pulsatile release compositions of milnacipran |
WO2004067039A1 (fr) * | 2003-01-28 | 2004-08-12 | Collegium Pharmaceutical, Inc. | Compositions multiparticulaires de milnacipran destinees a etre administrees par voie orale |
US7632521B2 (en) * | 2003-07-15 | 2009-12-15 | Eurand, Inc. | Controlled release potassium chloride tablets |
US20050214388A1 (en) * | 2004-02-18 | 2005-09-29 | Gorham Thomas R | Multivitamin formulations containing controlled-release magnesium |
US20060252831A1 (en) * | 2005-05-06 | 2006-11-09 | Christopher Offen | Method for the treatment of magnesium and potassium deficiencies |
US20060252830A1 (en) * | 2005-05-06 | 2006-11-09 | Brandon Stephen F | Method for the treatment of magnesium and potassium deficiencies |
US8163301B2 (en) | 2007-03-22 | 2012-04-24 | Magceutics, Inc. | Magnesium compositions and uses thereof for metabolic disorders |
US8445020B2 (en) * | 2008-05-19 | 2013-05-21 | Pharmalyte Solutions, Llc | High-loading, controlled-release magnesium oral dosage forms and methods of making and using same |
US9707253B2 (en) * | 2008-05-19 | 2017-07-18 | Pharmalyte Solutions, Llc | High-loading, controlled-release magnesium oral dosage forms and methods for making and using same |
US20100172979A1 (en) * | 2008-12-24 | 2010-07-08 | Zhongshui Yu | Controlled-release formulations |
CN102573496B (zh) | 2009-07-01 | 2015-08-26 | 玛格塞蒂克斯公司 | 缓释镁组合物及其用途 |
AR101476A1 (es) | 2014-08-07 | 2016-12-21 | Acerta Pharma Bv | Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk) |
JP2017214352A (ja) * | 2016-04-19 | 2017-12-07 | ファーマライト ソリューションズ, エルエルシーPharmalyte Solutions, LLC | 高負荷、制御放出マグネシウム経口剤形およびそれを作製および使用するための方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3456049A (en) * | 1965-05-25 | 1969-07-15 | Ciba Geigy Corp | Gradual-release tablet |
JPS57156419A (en) * | 1981-03-24 | 1982-09-27 | Kyowa Chem Ind Co Ltd | Remedy for sideropenia |
NL8500724A (nl) * | 1985-03-13 | 1986-10-01 | Univ Groningen | Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan. |
US4670248A (en) * | 1985-08-15 | 1987-06-02 | International Minerals & Chemical Corp. | Olivine bolus |
GB8521350D0 (en) * | 1985-08-28 | 1985-10-02 | Euro Celtique Sa | Analgesic composition |
US4756911A (en) * | 1986-04-16 | 1988-07-12 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
-
1989
- 1989-06-08 US US07/363,038 patent/US5002774A/en not_active Expired - Lifetime
-
1990
- 1990-06-04 CA CA002018167A patent/CA2018167C/fr not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5002774A (en) | 1991-03-26 |
CA2018167C (fr) | 1999-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2018167A1 (fr) | Comprime a delitement progressif | |
CA1240925A (fr) | Formes posologiques de medicaments solides a liberation controlee a base de melanges d'ethers de cellulose non ioniques hydrosolubles et d'agents de surface anioniques | |
US4666705A (en) | Controlled release formulation | |
CA1316108C (fr) | Formulation pour la preparation de medicaments a liberation continue pour administration par voie orale | |
EP2238975B1 (fr) | Système d'administration de médicament contrôlée par rétention gastrique | |
CA1331344C (fr) | Formes pharmaceutiques a liberation prolongee contenant de la hydroxypropyl-methylcellulose et des carboxylates de metaux alcalins | |
US4610870A (en) | Controlled release formulation | |
AU719170B2 (en) | Pharmaceutical compressed tablet characterized by a high increase in volume by contact with biological fluids | |
US9439851B2 (en) | Gastric retention system | |
US5582838A (en) | Controlled release drug suspension delivery device | |
CA2084680A1 (fr) | Procede de fabrication de matrices cellulosiques poreuses | |
CA2085871C (fr) | Microcapsule | |
IE881195L (en) | Ibuprofen sustained release matrix | |
WO1996012478A1 (fr) | Dispositif de liberation commandee de nifedipine | |
IL126477A (en) | Controlled Release Drugs Containing Amylose and Hydroxypropylmethylcellulose Based Substance | |
JP2004531399A5 (fr) | ||
AU2793989A (en) | Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained | |
AU2002258002A1 (en) | A process for the preparation of tablets from pharmaceutically active substances having unfavourable tabletting properties with a granulating liquid comprising microcrystalline cellulose | |
KR100315618B1 (ko) | 베타-페닐프로피오페논유도체의지연방출성미세정제 | |
Herman et al. | Instability of drug release from anhydrous theophylline-imcrocrystalline cellulose formulations | |
IE902292L (en) | Sustained release pharmaceuticals | |
CA1225028A (fr) | Comprimes a delitement progressif | |
MY130959A (en) | Oral preparation, comprising at least one pharmaceutical active compound in a matrix which is swellable in aqueous medium | |
KR900009060A (ko) | 트리메부틴 기재 서방형 조성물 및 그 제조 방법 | |
CA2469339A1 (fr) | Gelules a liberation lente de chlorhydrate de propafenone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |